According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are HK$0.37 Billion. In 2023 the company made an earning of -HK$7.38 Billion a decrease over its 2022 earnings that were of HK$1.96 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | HK$0.55 B | -107.57% |
2023 | -HK$7.38 Billion | -475.59% |
2022 | HK$1.96 B | 25.8% |
2021 | HK$1.56 B | 84.32% |
2020 | HK$0.84 B | 84.69% |
2019 | HK$0.45 B | -125.13% |
2018 | -HK$1.83 Billion | 100.62% |
2017 | -HK$0.92 Billion | 43.12% |
2016 | -HK$0.64 Billion | -42.73% |
2015 | -HK$1.12 Billion | -24.76% |
2014 | -HK$1.48 Billion | -30.49% |
2013 | -HK$2.13 Billion | 275.65% |
2012 | -HK$0.57 Billion | 11.56% |
2011 | -HK$0.51 Billion | 9.38% |
2010 | -HK$0.47 Billion | -15.21% |
2009 | -HK$0.55 Billion |